Speaker illustration

Doctor Arthur Mader

VIVIT Institute, Feldkirch (Austria)

Member of:

European Society of Cardiology

The ceramide-based Coronary Event Risk Test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes mellitus as well as in those without diabetes

Event: ESC CONGRESS 2019

Topic: Biomarkers

Session: Diabetes and the heart

Thumbnail

Serum ceramides and type 2 diabetes are mutually independent predictors of cardiovascular events in patients with peripheral artery disease

Event: ESC CONGRESS 2019

Topic: Biomarkers

Session: Vascular disease

Thumbnail

This platform is supported by

logo Novo Nordisk